& Hua, X
This type of program includes close monitoring of progress, adjusting the medication as needed, and providing ongoing support to help patients reach their weight loss goals safely and effectively
More serious, though much rarer, risks have been identified, including a potential increased risk of pancreatitis and gallbladder problems
CLICK HERE FOR MORE HEALTH STORIES If a GLP-1 patient becomes too fatigued to exercise, develops nutritional deficiencies or loses excessive muscle mass, Kahn warned that this reflects a "monitoring problem" rather than a medication problem, as these medications "require close clinical oversight."
Simply put, GLP-1s are a class of medications used in the treatment of type 2 diabetes and obesity
GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: a crossover, randomised, placebo-controlled trial
